AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,554,080 | +17.7% | 3,767,380 | +8.7% | 0.34% | +20.5% |
| Q2 2023 | $161,891,972 | +31.4% | 3,467,380 | +7.7% | 0.28% | +4.4% |
| Q1 2023 | $123,225,130 | -30.7% | 3,220,730 | -0.7% | 0.27% | -60.5% |
| Q4 2022 | $177,766,542 | +65.1% | 3,243,915 | +2.6% | 0.69% | +97.1% |
| Q3 2022 | $107,675,000 | +334.9% | 3,162,259 | +20.7% | 0.35% | +419.4% |
| Q2 2022 | $24,756,000 | -27.9% | 2,619,671 | +8.3% | 0.07% | -2.9% |
| Q1 2022 | $34,335,000 | -34.5% | 2,419,671 | -2.4% | 0.07% | -28.9% |
| Q4 2021 | $52,445,000 | -5.4% | 2,479,671 | 0.0% | 0.10% | +3.2% |
| Q3 2021 | $55,421,000 | -10.3% | 2,479,671 | -0.4% | 0.09% | +3.3% |
| Q2 2021 | $61,770,000 | -14.7% | 2,489,694 | -0.2% | 0.09% | -15.7% |
| Q1 2021 | $72,402,000 | +22.7% | 2,495,771 | +9.1% | 0.11% | +12.5% |
| Q4 2020 | $59,021,000 | -16.0% | 2,287,630 | +0.3% | 0.10% | -26.2% |
| Q3 2020 | $70,223,000 | +182.2% | 2,280,707 | +128.4% | 0.13% | +106.3% |
| Q2 2020 | $24,880,000 | +26.9% | 998,374 | +8.0% | 0.06% | -25.0% |
| Q1 2020 | $19,601,000 | +100.9% | 924,594 | +110.3% | 0.08% | +133.3% |
| Q4 2019 | $9,756,000 | -14.7% | 439,594 | -12.6% | 0.04% | -10.0% |
| Q3 2019 | $11,437,000 | +170.3% | 502,722 | +127.5% | 0.04% | +135.3% |
| Q2 2019 | $4,232,000 | – | 221,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| University of Wisconsin Foundation | 103,816 | $5,251,013 | 6.02% |
| Boxer Capital, LLC | 1,676,733 | $84,809,155 | 4.52% |
| Redmile Group, LLC | 1,769,684 | $89,510,617 | 4.26% |
| Ghost Tree Capital, LLC | 250,000 | $12,645,000 | 4.16% |
| Logos Global Management LP | 600,000 | $30,348,000 | 4.05% |
| COMMODORE CAPITAL LP | 565,000 | $28,577,700 | 3.34% |
| Yiheng Capital Management, L.P. | 1,221,674 | $61,792,271 | 3.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 200,000 | $10,116,000 | 3.07% |
| Atlas Venture Life Science Advisors, LLC | 359,251 | $18,170,915 | 2.81% |
| Perceptive Advisors | 1,619,425 | $81,910,517 | 2.73% |